Relationship between fibrinolytic system and neurological diseases

被引:0
|
作者
Ascension Zea, Maria [1 ]
Emilio Bermejo, Pedro [2 ]
Carrillo, Francisco [3 ]
机构
[1] Hosp Henares, Serv Neurol, E-28822 Coslada, Madrid, Spain
[2] Hosp Univ Puerta Hierro, Serv Neurol, Madrid, Spain
[3] Hosp Univ Canarias, Serv Neurol, Tenerife, Spain
关键词
Blood coagulation; Epilepsy; Fibrinogen; Multiple sclerosis; Plasminogen; Plasminogen activator inhibitor; Stroke; Tissue plasminogen activator; TISSUE-PLASMINOGEN-ACTIVATOR; INDUCED DOPAMINE RELEASE; A-BETA DEGRADATION; INHIBITOR-1; PAI-1; MYOCARDIAL-INFARCTION; ALZHEIMERS-DISEASE; MATRIX-METALLOPROTEINASE; 4G/5G POLYMORPHISM; T-PA; GENE;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction. The fibrinolytic system, also named plasminogen system is formed by a group of molecules that transforms plasminogen in its active form plasmine, which is able to participate in a number of pathophysiological processes Aim. To carry out a review of the literature and an analysis of the relationship between fibrinolytic system and neurological diseases and its potential therapeutic implications. Development. The fibrinolytic system has been involved in many different pathologies Although its role in neurological diseases has always been thought to be scarce, many relations have been recently established. This way, fibrinolytic system seems to be involved not only in cerebrovascular diseases but also in epilepsy, inflammatory diseases such as multiple sclerosis, alterations of the dopaminergic system, learning disorders and several lesions of the peripheral nervous system. Different genotypes of several components of this system have been related as risk or protector factors to the development of these neurological diseases and information to this respect is rapidly increasing Conclusions. A better knowledge about the relations between the fibrinolytic system and neurological diseases could clarify several aspects about their pathophysiology and it could suppose future prevention and treatment lines.
引用
收藏
页码:295 / 301
页数:7
相关论文
共 50 条
  • [21] Immunosenescence in Neurological Diseases-Is There Enough Evidence?
    Rommer, Paulus S.
    Bsteh, Gabriel
    Zrzavy, Tobias
    Hoeftberger, Romana
    Berger, Thomas
    BIOMEDICINES, 2022, 10 (11)
  • [22] Coagulation Pathways in Neurological Diseases: Multiple Sclerosis
    Ziliotto, Nicole
    Bernardi, Francesco
    Jakimovski, Dejan
    Zivadinov, Robert
    FRONTIERS IN NEUROLOGY, 2019, 10
  • [23] Psychiatric Manifestations of Neurological Diseases: A Narrative Review
    Maristany, Anthony J.
    Sa, Brianna C.
    Murray, Cameron
    Subramaniam, Ashwin B.
    Oldak, Sean E.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (07)
  • [24] The Role of Ketogenic Diet in the Treatment of Neurological Diseases
    Dynka, Damian
    Kowalcze, Katarzyna
    Paziewska, Agnieszka
    NUTRIENTS, 2022, 14 (23)
  • [25] Application of infrared spectroscopy in the study of neurological diseases
    Turker, Sevgi
    BIOMEDICAL SPECTROSCOPY AND IMAGING, 2012, 1 (04) : 303 - 323
  • [26] Psychotic Symptoms in Patients With Major Neurological Diseases
    Kim, Jong S.
    Hong, Seung-Bong
    Park, Keun-Woo
    Lee, Allen T. C.
    JOURNAL OF CLINICAL NEUROLOGY, 2024, 20 (02): : 153 - 165
  • [27] Gut microbiota: a new insight into neurological diseases
    Liu, Lanxiang
    Wang, Haiyang
    Chen, Xueyi
    Xie, Peng
    CHINESE MEDICAL JOURNAL, 2023, 136 (11) : 1261 - 1277
  • [28] Inflammation and gliosis in neurological diseases - clinical implications
    Czlonkowska, Anna
    Kurkowska-Jastrzebska, Iwona
    JOURNAL OF NEUROIMMUNOLOGY, 2011, 231 (1-2) : 78 - 85
  • [29] Transcranial Magnetic Stimulation in the Treatment of Neurological Diseases
    Somaa, Fahad A.
    de Graaf, Tom A.
    Sack, Alexander T.
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [30] Obesity and Neurological Diseases
    Winter, Y.
    AKTUELLE NEUROLOGIE, 2015, 42 (03) : 141 - 147